Your browser doesn't support javascript.
loading
Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma.
Tomska, K; Kurilov, R; Lee, K S; Hüllein, J; Lukas, M; Sellner, L; Walther, T; Wagner, L; Oles, M; Brors, B; Huber, W; Zenz, T.
Afiliação
  • Tomska K; Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany. katarzyna.tomska@med.uni-heidelberg.de.
  • Kurilov R; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany.
  • Lee KS; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Hüllein J; Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany.
  • Lukas M; Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany.
  • Sellner L; Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany.
  • Walther T; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Wagner L; Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany.
  • Oles M; Molecular Therapy in Haematology and Oncology & Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany.
  • Brors B; Genome Biology Unit, EMBL, Heidelberg, Germany.
  • Huber W; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany.
  • Zenz T; Genome Biology Unit, EMBL, Heidelberg, Germany.
Sci Rep ; 8(1): 12046, 2018 08 13.
Article em En | MEDLINE | ID: mdl-30104685

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article